Bottom line
Is ARVIX a good fund? The bottom line
ARVIX is the Institutional share class of Arga International Value Fund, an actively managed international stock mutual fund from SEI.
Its expense ratio is 0.75% — about $75 a year on every $10,000 invested, cheaper than 67% of international stock funds we track.
It returned +39.7% over one year (as of Dec 31, 2025, per its prospectus).
With $178 million in net assets and 78 holdings, its largest position is Prosus N.V. (5.0%) and the top 10 make up 35.1% of the portfolio.
Updated Nov 19, 2026
What ARVIX invests in
The ARGA International Value Fund (the Fund) seeks long-term capital appreciation.
Under normal circumstances, the Fund invests primarily in equity securities of companies located in any part of the world and in other instruments, such as shares of exchange-traded funds (ETFs), that have economic characteristics similar to such securities. The Fund mainly invests in common stocks, but may also invest in depositary receipts (including American Depositary Receipts (ADRs), European Depositary Receipts (EDRs) and Global Depositary Receipts (GDRs)), preferred stocks, participation notes (P-Notes), private placements, ETFs and real estate investment trusts (REITs). Depositary receipts are certificates typically issued by a bank or trust company that represent ownership interests in securities of non-U.S. companies. Typically, the Fund invests in securities of companies with a market capitalization of at least $1 billion. The Fund may invest in securities denominated in any…
From the fund's prospectus (filed Apr 30, 2026).
ARVIX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| ARVIX | +39.7% | — | — |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What ARVIX costs
On a $10,000 investment, ARVIX's 0.75% expense ratio costs about $75 a year. The prospectus estimates $1,018 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
ARVIX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Prosus N.V. | 4.97% |
| 2 | Kering Sa | 4.57% |
| 3 | Nidec Corporation | 4.56% |
| 4 | Bayer Aktiengesellschaft | 3.94% |
| 5 | Novo Nordisk A/s | 3.40% |
| 6 | Rheinmetall Aktiengesellschaft | 3.10% |
| 7 | Gsk Plc | 3.09% |
| 8 | AerCap Holdings N.V. | 3.04% |
| 9 | Sika AG | 2.22% |
| 10 | Axa Sa | 2.17% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 35.1% of the fund. See all top 25 holdings and asset mix →